KEYNOTE-585: Disappointing results for perioperative pembrolizumab in gastric cancer Editorial


Author: Ilson, D. H.
Title: KEYNOTE-585: Disappointing results for perioperative pembrolizumab in gastric cancer
Keywords: event free survival; overall survival; cisplatin; fluorouracil; placebo; cancer combination chemotherapy; capecitabine; cancer adjuvant therapy; progression free survival; epidermal growth factor receptor 2; editorial; docetaxel; folinic acid; adjuvant chemotherapy; microsatellite instability; stomach cancer; neoadjuvant chemotherapy; drug therapy; oxaliplatin; pyrimidine; gastric cancer; perioperative care; pathological complete response; pathologic complete response; fibroblast growth factor receptor; gimeracil plus oteracil potassium plus tegafur; capecitabine plus oxaliplatin; nivolumab; claudin; human; pembrolizumab; durvalumab; atezolizumab; toripalimab; tislelizumab
Journal Title: Translational Gastroenterology and Hepatology
Volume: 10
ISSN: 2415-1289
Publisher: Ame Publ Co  
Date Published: 2025-01-30
Start Page: 18
Language: English
DOI: 10.21037/tgh-24-57
PROVIDER: scopus
DOI/URL:
Notes: Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. David H Ilson
    434 Ilson